The US will pay Moderna $176 million to develop an mRNA vaccine against pandemic flu

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on telegram
Share on email
Share on reddit
Share on whatsapp
Share on telegram


FILE – A patient receives a flu shot on Oct. 28, 2022, in Lynwood, California. On Tuesday, July 2, 2024, the U.S. Department of Health and Human Services announced plans to pay Moderna $176 million to develop an mRNA vaccine to treat bird flu in people as cases in cows increase. Dairy farms continue to increase across the country. (AP Photo/Mark J. Terrill, File)



This story originally appeared on ABCNews.go.com read the full story

Support fearless, independent journalism

We are not owned by a billionaire or shareholders – our readers support us. Donate any amount over $2. BNC Global Media Group is a global news organization that delivers fearless investigative journalism to discerning readers like you! Help us to continue publishing daily.

Support us just once

We accept support of any size, at any time – you name it for $2 or more.

Related

More

1 2 3 6,300

Don't Miss